Stockreport

MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics [Yahoo! Finance]

MDxHealth SA  (MDXH) 
PDF 15, 2025, MDxHealth SA (NASDAQ:MDXH) announced the completion of its acquisition of Bio-Techne Corporation's ExoDx business, including the ExoDx Prostate test. This $15 [Read more]